CIPLA TAKE'S ON ROCHE (Part II)

Cipla recently introduced Valcept, a generic equivalent of Roche's patented Valcyte, an anti infective predominantly used by HIV patients:

"This is the second instance of Cipla launching a low-cost version of Roche’s patent-protected drug after India's amended patent law began to recognise product patents or patents for specific drugs instead of protection to the processes through which medicines are produced. While Roche had dragged Cipla to the court on the earlier occasion, it is yet to seek legal remedy on valganciclovir.